Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAOB | P27338 | 2/20 | 0.50 |
| ▸ | IDO1 | P14902 | 1/20 | 0.48 |
| ▸ | FFAR1 | O14842 | 1/20 | 0.47 |
| ▸ | MAOA | P21397 | 1/20 | 0.47 |
| ▸ | LMNA | P02545 | 1/20 | 0.46 |
| ▸ | MAPT | P10636 | 1/20 | 0.46 |
| ▸ | RXFP1 | Q9HBX9 | 1/20 | 0.46 |
| ▸ | HTR2A | P28223 | 1/20 | 0.45 |
| ▸ | SIGMAR1 | Q99720 | 1/20 | 0.44 |
| ▸ | HDAC3 | O15379 | 1/20 | 0.44 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.44 |
| ▸ | ADRA1A | P35348 | 1/20 | 0.44 |
| ▸ | HDAC4 | P56524 | 1/20 | 0.44 |
| ▸ | SLC6A3 | Q01959 | 1/20 | 0.44 |
| ▸ | HDAC1 | Q13547 | 1/20 | 0.44 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.44 |
| ▸ | HDAC7 | Q8WUI4 | 1/20 | 0.44 |
| ▸ | HDAC2 | Q92769 | 1/20 | 0.44 |
| ▸ | HDAC10 | Q969S8 | 1/20 | 0.44 |
| ▸ | HDAC11 | Q96DB2 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL14890565 | 0.98 | MAPT (0.48) | MAOBIDO1FFAR1MAOALMNA | |
| SCHEMBL4920782 | 0.98 | MAPT (0.48) | MAOBIDO1FFAR1MAOALMNA | |
| SCHEMBL4406119 | 0.94 | IDO1 (0.55) | MAOBIDO1FFAR1MAOALMNA | |
| SCHEMBL1101315 | 0.85 | CA1 (0.48) | MAOBIDO1FFAR1MAOALMNA | |
| SCHEMBL7434838 | 0.85 | FFAR1 (0.49) | MAOBIDO1FFAR1MAOALMNA | |
| SCHEMBL28784998 | 0.83 | MAPT (0.50) | MAOBIDO1FFAR1LMNAMAPT | |
| SCHEMBL27522937 | 0.83 | MAPT (0.50) | MAOBIDO1FFAR1LMNAMAPT | |
| SCHEMBL28170101 | 0.82 | MAPT (0.49) | MAOBIDO1FFAR1LMNAMAPT | |
| SCHEMBL4413671 | 0.81 | TAAR1 (0.45) | MAOBIDO1FFAR1MAOAHTR2A | |
| SCHEMBL10773558 | 0.81 | TAAR1 (0.45) | MAOBLMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 24 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-119978387-A | Three-component synthesis method of polyphosphonate | 华南理工大学 | 2025-05-13 | — | — | CN | claimed |
| CN-119978387-A | Three-component synthesis method of polyphosphonate | 华南理工大学 | 2025-05-13 | — | — | CN | disclosed |
| CN-116685715-A | Substrate, selective film deposition method, deposited film of organic substance, and organic substance | 中央硝子株式会社 | 2023-09-01 | — | — | CN | disclosed |
| US-7635748-B2 | Resin and article molded therefrom | TORAY INDUSTRIES, INC. (JP) | 2009-12-22 | — | — | US | disclosed |
| CN-100497335-C | Optical resolution method substituting oxyphosphonate acetate | SHANGHAI MEDICAL INDUSTRY INST (CN) | 2009-06-10 | — | — | CN | disclosed |
| CN-100488969-C | Optically active substituted oxyphosphonate salt acetate and its use | SHANGHAI MEDICAL INDUSTRY INST (CN) | 2009-05-20 | — | — | CN | disclosed |
| EP-1270646-B1 | RESIN COMPOSITION AND ARTICLES MOLDED THEREFROM | TORAY INDUSTRIES (JP) | 2008-11-26 | — | — | EP | disclosed |
| US-20080139778-A1 | Resin and article molded therefrom | TAKANISHI KEIJIRO | 2008-06-12 | — | — | US | disclosed |
| CN-1955185-A | Optical active substitution oxyphosphonate salt acetate and its use | SHANGHAI MEDICAL INDUSTRY INST (CN) | 2007-05-02 | — | — | CN | disclosed |
| CN-1955176-A | Optical separation method substituting oxyphosphonate acetate | SHANGHAI MEDICAL INDUSTRY INST (CN) | 2007-05-02 | — | — | CN | disclosed |
| EP-1270646-A1 | RESIN COMPOSITION AND ARTICLES MOLDED THEREFROM | TORAY INDUSTRIES, INC. (JP) | 2003-01-02 | — | — | EP | disclosed |
| EP-0229520-B1 | ORALLY ACTIVE PHOSPHONYL HYDROXYACYL PROLINES AND PROCESSES FOR PREPARING PHOSPHONYL HYDROXYACYL PROLINES | E.R. Squibb & Sons, Inc. (US) | 1990-05-30 | — | — | EP | disclosed |
| EP-0350138-A2 | Processes for preparing phosphonyl hydroxyacyl prolines | E.R. SQUIBB & SONS, INC. (US) | 1990-01-10 | — | — | EP | disclosed |
| EP-0097534-B1 | PHOSPHONYL HYDROXYACYL AMINO ACID DERIVATIVES AS ANTIHYPERTENSIVES | E.R. Squibb & Sons, Inc. (US) | 1988-09-21 | — | — | EP | disclosed |
| US-4703043-A | Phosphonyl hydroxyacyl amino acid derivatives as antihypertensive | E. R. SQUIBB & SONS, INC. (US) | 1987-10-27 | — | — | US | disclosed |
| EP-0229520-A1 | Orally active phosphonyl hydroxyacyl prolines and processes for preparing phosphonyl hydroxyacyl prolines | E.R. Squibb & Sons, Inc. (US) | 1987-07-22 | — | — | EP | disclosed |
| US-4616005-A | Phosphonyl hydroxyacyl amino acid derivatives as antihypertensives | E. R. SQUIBB & SONS, INC. (US) | 1986-10-07 | — | — | US | disclosed |
| EP-0120728-A1 | Thiazine and thiazepine containing compounds | E.R. Squibb & Sons, Inc. (US) | 1984-10-03 | — | — | EP | disclosed |
| US-4452790-A | Phosphonyl hydroxyacyl amino acid derivatives as antihypertensives | E. R. SQUIBB & SONS, INC. (US) | 1984-06-05 | — | — | US | disclosed |
| EP-0097534-A2 | Phosphonyl hydroxyacyl amino acid derivatives as antihypertensives | E.R. Squibb & Sons, Inc. (US) | 1984-01-04 | — | — | EP | disclosed |